Product Liability Archive » February, 2014

Product Liability - February, 2014

352 articles

• BP Can't Get Secret Docs In Deepwater Settlement Probe
• As Patton Boggs Seeks New Merger, Chevron Suit Looms
• NC Issues Duke Violation Notices Over Coal Ash Spill
• CBS, Ford, Others Hit With Asbestos Suit
• Developer Seeks Dismissal Of $100M Helicopter Crash Suit
• Steel Co. Sues Liberty Mutual For Defense In BP Defect Row
• Riddell Helmet Led To Football Player's Brain Injury, Jury Told
• Lawmaker Unrolls House Version Of Chemical Safety Reform
• Tobacco Plain Packaging Divides WTO At IP Council Meeting
• FDA Updates Guidance On Avoiding Off-Label Promotion
• Pa. High Court's Design Ruling Revives Fen-Phen Suit
• Female Powerbrokers Q&A: Covington's Christine Haskett
• Female Powerbrokers Q&A: Holland & Knight's Anita Mosner
• Pa. Court Affirms Sittig Cortese Fee Award In RE Dispute
• FCA Suits Over Poor Drug Quality Are Down But Not Out
• Murphy Oil Can't Seek Spill Damages From Coast Guard
• 7th Circ. Maintains Liquor Liability Exclusion
• Pom Fights 9th Circ. Ruling In Coca-Cola Juice Label War
• Fla. Justices Rule On Limits For Defendant Status Changes
• Fla. High Court Ditches Appeals In 2 Engle Cases
• Boiron Ducks Class Cert. In Suit Over Flu Remedy Label
• Duane Reade Pays $22M To Settle Litigation Over Truck Injury
• McDonald's, Others Escape Cancer Warning Suits Once Again
• Health Care Orgs Call On FDA To Stop Painkiller Launch
• Cisco Dodges Chinese Dissidents' Suit Over Surveillance IT
• Insurer Can't Cap Defense Costs In Crane Collapse Suits
• Senate Dems Move To Ban E-Cig Ads Aimed At Kids
• Bulk Of $4M Fen-Phen Referral Fee Award Upheld On Appeal
• Bumble Bee Faces Failure-To-Warn Suit Over Mercury In Tuna
• FDA, EMA Back Safety Of Diabetes Drugs Targeted In MDL
• FRCP Discovery Amendments Prove Highly Controversial
• Train Crash Victims' Ch. 11 Plan Unworkable, Trustee Says
• Suncor Energy Coughs Up $2M To Settle Oil Spill Case
• GM Faces Up To $35M Fine In NHTSA Recall Probe
• W.Va. Plavix Ad Claims Remanded To State Court
• Maybelline Buyers Seek Class Cert. In False Ad Suit
• Female Powerbrokers Q&A: Buchalter's Shawn Christianson
• Female Powerbrokers Q&A: Robins Kaplan's Hollis Salzman
• Home Depot Customer Files Class Action Over Shoddy Hose
• White House, FDA Overhaul Nutrition Label Guidelines
• High Court's Whirlpool Snub Casts Doubt On Comcast's Reach
• Subcontractors Can't Shake Claims Over NYC Crane Collapse
• Panel Revives Fla. City's Suit Over Deepwater Horizon Funds
• Attys Can't Freeze Fees From $12M Bronx Pollution Deal
• Hertz Hides Currency Conversion Fees, Class Action Claims
• Atty Wins Stay In BP Suit Amid Probe Into Spill Fund Fraud
• FDA Spied On Staff Without Considering Legal Risks: Report
• EU Lawmakers Approve Strict Rules For Tobacco, E-Cigarettes
• BMW Gets Faulty Navigation System Suit Trimmed
• SEPTA's Sovereign Immunity Backed By Appeals Court
• Siemens Asks Court To Toss $20M Faulty-Turbine Suit
• Travelers Bests Northrop Grumman In Cleanup Row
• 3rd Circ. Ruling Over NJ Merit Statute May Have Nat'l Impact
• Crum Sues To Avoid Covering K. Hovnanian In Defects Row
• Asbestos Attys Fight CSX's Racketeering Claims In 4th Circ.
• FDA Won't Change Medical Device Notification Rules
• GSK Can't Shake Calif. County's Avandia False Ad Claims
• Goodman Faces $803M In Damages In Air Conditioner Action
• Female Powerbrokers Q&A: Sedgwick's Stephanie Sheridan
• Female Powerbrokers Q&A: Pryor Cashman's Colleen Caden
• Armstrong, Supplement Co. Cycle Past False Marketing Suit
• Mattel Beats Cert. For Moldy Baby-Seat Class
• J&J, Ethicon Sued Over Surgical Stapler Misfire
• 7th Circ. Reminder On Challenging A Class's Predominance
• Firms Kick Off Benicar Diarrhea Suits Against Daiichi
• Miami Hotel-Water Suit Should Be Covered, 11th Circ. Told
• Honda Window Defect Plaintiffs Pledge To Renew Cert. Fight
• Olive Oil Importer Can't Escape Mislabeling Claims
• FDA Rips Research Co. Over Unapproved Electromagnet Trials
• GM Ignition Switch Recall Expanded To 1.3M Vehicles
• DOT Orders Bakken Oil Testing Before Shipping By Rail
• FDA Announces Recalls Of Trachea Tube, Catheter Devices
• White House To Announce Updates To Nutrition Labels
• McGlinchey Stafford Lands Litigation Ace In Fort Lauderdale
• The Unstoppable Trailblazer: Judge Shira Scheindlin
• 5th Circ. Axes State Claims Over BP Deepwater Horizon Spill
• 49ers Say Fan Filed Gunshot Liability Suit Too Late
• FDA Blasts Another Indian Drug Firm Over Suspect Records
• Female Powerbrokers Q&A: Dentons' Kara Baysinger
• Female Powerbrokers Q&A: Winston & Strawn's Joan Fife
• Philips Brushes Off Claims In Defective Toothbrush Suit
• GM Says Electronic Glitch In Pickups Doesn't Warrant Recall
• Plastics Co. Dodges Safety Fines Over Fatal Heater Explosion
• Total, Endo Units Hit With Vaginal Mesh Suit In Texas
• High Court's Whirlpool Snub Invites More Defect Suits
• GMO Labeling Bill Unveiled In Calif.
• Crum & Forster Says No Coverage For Radon-Tainted Homes
• Listeria Death Prompts Cheese Recall
• DOJ Sues 4 Calif. Cos. To Block Import Of Dangerous Toys
• Zoloft False Ad Suit Time-Barred, Judge Finds
• High Court Refuses Widow's Appeal In Hyatt Terrorism Suit
• J&J Hid Topamax Birth Defect Risks, Philly Jury Hears
• Calif. Appeals Court Sides With KB In Allstate Repair Row
• High Court Moldy Washer Ruling May Increase Class Actions
• States Acting Hastily In Pushing E-Cigarette Taxes
• Kroger Settles 'Popcorn Lung' Row After Landmark Award
• High Court Won't Hear Citgo Appeal In $180M Oil Spill Case
• Firm That Bragged About PVC Win Sued For Libel
• Female Powerbrokers Q&A: Bingham's Debra Fischer
• Female Powerbrokers Q&A: Nossaman's Nancy Smith
• High Court Rebuffs Moldy Washer Class Cert. Appeals
• Ex-College Head Coach Ducks Suit Over Football Player's Death
• Bankrupt Firm Blamed For W.Va. Chemical Spill To Wind Down
• Railroads Reach Crude Oil Shipping Safety Deal With DOT
• 4th Circ. Axes Whistleblower's FCA Suit Against Omnicare
• 5th Circ. Affirms Brand, Generic Wins In Reglan Suits
• FDA Sued Over 'Safe' Designation Of Food Additives
• FDA Chief Predicts Long Road For India Quality Reforms
• How Big Oil Is Trying To Tar Lobbying And PR As Extortion
• Prop 65 Continues To Cause Headaches For Calif. Companies
• BMW Slides Out Of Rollaway Class Action For 2nd Time
• Atlas Rips DEP Findings On Western Pa. Frack Site
• Novartis Can't Shake $1.3M Zometa Verdict
• DOI Calls For Raised $134M Oil Spill Liability Cap
• FDA Plans Overhaul Of Over-The-Counter Drug System
• GSK Cleared To Appeal RICO Questions In Avandia Suits
• CORRECTED: Endo Inks $193M Deal Over Off-Label Lidoderm Marketing
• FDA Issues 1st Ban Under Tobacco Control Act
• Silica Exposure Lawsuits: The Next Toxic Tort?
• Lewis Brisbois Grabs Nelson Levine Pros For Pa. Expansion
• Wal-Mart Beats Service Plan Fraud Class Action
• Female Powerbrokers Q&A: Ropes & Gray's Jane Goldstein
• Female Powerbrokers Q&A: Snell & Wilmer's Barb Dawson
• Law360 Product Liability Editorial Advisory Board
• Pa. Appeals Court Won't Rehear Fixodent Evidence Dispute
• 9th Circ. Refuses To Revive Novartis Jaw Injury Suit
• J&J Mesh Suits Belong In Federal Court, 10th Circ. Told
• Group Wants McDonald's, KFC Cancer Warning Suits Revived
• EPA Pitches New Rules, Age Limit For Pesticide Use On Farms
• NY Panel Shields IBM From Medical Monitoring Damages
• NHTSA Should Probe GM On 'Overdue' Chevy Recall, Atty Says
• Phillips & Cohen Accused Of Trade Secrets Theft
• Chobani Sinks Yogurt Ingredient Labeling Class Action
• Rice Sellers Threatened With Prop 65 Suits Over Lead, Arsenic
• Insurers Don't Owe $11M For Gas Shortage, 4th Circ. Says
• Endo Puts Aside $520M For Vaginal Mesh Litigation
• FDA Agrees To FSMA Rollout Deadlines In Settlement
• W.Va. High Court Finds 1 Occurrence In Carbon Monoxide Case
• Texas Atty's Appeal For Cut Of Personal Injury Award Axed
• J&J Blood Thinner Xarelto Caused Bleeding, Suit Says
• Female Powerbrokers Q&A: Choate's Melissa Tearney
• Female Powerbrokers Q&A: Littler's Lee Schreter
• Drone D-Day: How NTSB Case Could Impact FAA Authority
• Soda Tax, Warning Labels Have Broad Support In Calif.: Poll
• FDA Import Reforms To Fuel Fights Over Drugmaking Slip-Ups
• FTC Bags $2M False Ad Win Against Diabetes Supplement Co.
• FDA, Consumer Groups Settle FSMA Rollout Spat
• FDA Updates Guidance On Lab Data For New Drugs
• Companies Fear CPSC's New Transparency Will Fuel Lawsuits
• NTSB Urges More Metro-North Safety Changes Post-Crash
• 9th Circ. Clarifies Scope Of Rule 26 Expert Discovery
• Enviro Group Slams Agencies Over NJ-NY Oil Spill Plan
• NY Court Upholds Suit Over Fire Death From Floor Finish
• Okla. Bill Would Buck E-Cigarette Tax Trend
• New Philly Mass Tort Program Created For Pelvic Mesh Suits
• Female Powerbrokers Q&A: Steptoe's Mimi Addy
• Female Powerbrokers Q&A: Ballard Spahr's Mary Mullany
• How To Use Risk Analysis To Calculate Settlement Value
• Attys Get Fee Fund In Calif. Toyota Acceleration Suits
• The Captain Of The Mother Court: Judge Loretta Preska
• Pfizer, GSK To Have Imported Drugs Fast-Tracked By FDA
• JPML Centralizes Lipitor Diabetes Suits In SC
• FDA Vows To Collaborate More With Indian Drug Regulators
• Donziger Can't Stay Chevron Suit Pending 2nd Circ. Ruling
• JPML Consolidates PVC Deck Durability Suits In NJ
• FDA Urged To Back Off Menu Labeling Changes
• Is It Time To Recall The Term 'Recall'?
• CPSC, Manufacturers Blasted For Poor Recall Rates
• Enviros Urge NRC To Halt Licensing To Mull Reactor Study
• Insurer Seeks To Move $32M Reservoir Collapse Suit To NY
• EPA Hits 35 Renovation Cos. With Lead Exposure Fines
• J&J Wins 1st Vaginal Mesh Bellwether Trial
• FDA Eyes Overhaul Of Risk Disclosure In Pharma Ads
• EU Draws Line On Food, Enviro Regs In US Trade Talks
• Female Powerbrokers Q&A: Kaye Scholer's Lori Leskin
• Female Powerbrokers Q&A: Hirschler's Courtney Paulk
• FDA Warns Baxter Over Infusion Pump Quality Controls
• Cameron Fights To Keep $50M Deepwater Coverage Suit Afloat
• Litigation Funding Could Tip Scales In Engle Tobacco Cases
• 5th Circ. Adds New Wrinkle To Construction Defect Debate
• BP Urges Judge To Deny Ala. Motion For Deepwater Jury Trial
• Tesla Shareholders Must Nail Down False Claims, Judge Says
• Calif. Lawmaker Wants Warning On Sugary Drinks
• FDA Again Rejects J&J, Bayer Blood Thinner Expansion
• Keryx, CEO Dodge Investor Class Action Over Cancer Drug
• J&J's Discovery Mishaps Barred From Vaginal Mesh Trial
• Medisca Recalls L-Citrulline Lots Amid FDA Warning
• Judge Won't Recuse Self From BP Spill Obstruction Case
• Ky. Panel Quashes Asbestos Injury Suit Against Lorillard
• Texas Justices Pass On $72M Rig Worker Insurance Suit
• Injunction Likely In Case Over Diabetes Pill Ads, Judge Says
• Blu-Ray Player Buyers Say LG Sold Outdated Goods
• Female Powerbrokers Q&A: Hughes Hubbard's Bassey
• Female Powerbrokers Q&A: Mitchell Silberberg's Coyoca
• Contractor Can't Dodge Boeing's Airport Construction Suit
• P&G Dodges Denture Adhesive Claims In Pa. Court
• 6 Tips For Creating Effective Trial Graphics
• BP To Begin Medical Claim Payouts In $130M Deepwater Deal
• Chemical Co. Solvay Hit With NJ Water Contamination Suit
• Tobacco Cos. Ask 11th Circ. To Reverse $3M Punitive Award
• JPML Nixes Cargill's Truvia Suits Consolidation Attempt
• CPSC Demands Buckyballs Maker's Financial Records
• Boehringer Faces 2,000-Plus Pradaxa Injury Suits
• Ski Resorts Can't Be Blamed For Avalanches, Court Says
• 10th Circ. Told J&J Pelvic Mesh Suits Belong In State Court
• Calif. Consumers Denied Class Cert. In Sears Dryers Suit
• Female Powerbrokers Q&A: Goodwin Procter's Sharton
• Carnival Ducks Further Sanctions In Hot Tub Infection Row
• Female Powerbrokers Q&A: Levenfeld's Patti O'Connor
• K&L Picks Up Norton Rose Atty To Bolster Houston Office
• State Oilfield Anti-Indemnity Statutes May Null Contracts
• 'All Natural' Labels Don't Deceive Consumers, Flax USA Says
• W.Va. Doesn't Understand The Scientific Method: Part 2
• Enfamil Maker Fights Bid To Reinstate Infant Death Suit
• 3rd Circ. OKs $9M In Attys' Fees In VW Class Action
• Ford Can't 'Escape' Fuel Efficiency False Ad Suit
• Patriot Coal Ordered To Halt Plant Operations After Spill
• Dems Want E-Cigs Placed Under Tobacco Master Settlement
• Fla. Court Reverses Judgment For RJR In Smoker's Suit
• FDA Hammers Active Ingredient Maker Over 'Severe Hazard'
• Ruling Sets Unrealistic Product Safety Bar, NY Justices Hear
• CPSC Refuses To Neuter Product Info Disclosure Proposal
• Condo Builder Sues Insurer For Coverage Of $23M In Repairs
• Forensics Software Co. Beats Rival's IP, False Ad Suit
• OSHA Lays Out Rules For Food Safety Whistleblowers
• Cuomo Open To Tougher Standard For Scaffold Injury Liability
• Female Powerbrokers Q&A: Ballard Spahr's Emilie Ninan
• Female Powerbrokers Q&A: Steptoe's Lucinda Low
• W.Va. Doesn't Understand The Scientific Method: Part 1
• Cohen Milstein Joins Forces With Fla.'s Leopold Law
• Toyota Recalls 1.9M Prius Vehicles Over Software Glitch
• Graco Recalls 3.7M Car Seats For Defective Buckle
• Amgen Hit With FDA Warning Over Drug-Device Combos
• FDA To Review AstraZeneca Diabetes Drug For Heart Risks
• 9th Circ. To Reconsider Its Remand Of Teva Painkiller Suit
• FDA Panel Says Data Don't Show Naproxen Is Safer NSAID
• NFL Retirees Seek Stronger Voice In Concussion Deal Talks
• NC Asks Judge To Postpone Duke Coal Ash Settlement
• Ind. Supreme Court Stubs Out City's Smoking Ban
• Justices Urged To Take Up KBR Electrocuted-Soldier Case
• Mich. Drug Companies Now Less Immune Under Tort Reform
• Sens. Seek To Limit FDA's Health IT Regulatory Oversight
• FTC Says 1st Amendment Doesn't Shield Pom's Health Claims
• Seeger Weiss Says Vitamin Shoppe Trademark Suit Falls Short
• Pa. Court Asked To Void $20M Award For Bulldozer Mishap
• Walgreen Misled Buyers Of Homeopathic Remedies, Suit Says
• EPA Sets Notification Requirements For 35 Chemicals
• E-Cigarette Tax Hikes Gain Traction In Ore., Hawaii
• Hain Loses 3rd Bid To Ditch Suit Over 'Organic' Labels
• NY Leaders Push For Ban On Microbeads
• Female Powerbrokers Q&A: Ropes & Gray's Laurel FitzPatrick
• Female Powerbrokers Q&A: Baker Donelson's Donna Fraiche
• Medtronic Tells 10th Circ. Bone Device Suit Is Preempted
• Garlock Ruling Gives Asbestos Defendants Discovery Hammer
• Court Split Over Medical Device Claims Persists
• 2nd Circ. Says NJ Law Applies To $5M Insurance Suit
• Mars Recalls Rice After Rash Outbreaks At Schools
• Roche Looks To Sink $2M Accutane Verdict On Appeal
• 4th Circ. Revives $13M Liberty Mutual Bad-Faith Verdict
• Pfizer Says 2nd Circ. Can't Review Lipitor FCA Suit
• Expert Testimony Barred In Denture-Adhesive Mass Tort
• US Sailors Seek $1B From Tepco For Radiation Exposure
• Guac Maker Yucatan Can't Shake Cane Juice Labeling Suit
• Unilever To Pay $10M Over Hair Loss Tied To Suave Product
• Female Powerbrokers Q&A: FordHarrison's Tracey Jaensch
• Female Powerbrokers Q&A: McManis' Neda Mansoorian
• AIG Escapes Insurer's Suit Over Asbestos Claims Coverage
• Toyota May Ink $1B Deal To End Defective Vehicle Probe
• Philadelphia City Council OKs Tougher Demolition Rules
• FDA Updates Disclosure Rules On Medical Device Changes
• J&J Wants Discovery Mishaps Barred From Vaginal Mesh Trial
• 5 Lessons Doctors Can Take From FDA's Big Stem-Cell Win
• Donziger Says Chevron's RICO Suit Doesn't Stick
• Specialty Can Appeal $1B Asbestos Liability To 3rd Circ.
• Trader Joe's Pays $3.4M To End Suit Over 'All-Natural' Claims
• Timbers Hit With Ex-Soccer Player's $10M Concussion Suit
• As Concussion Cases Grow, Insurance Is In Doubt
• Bombardier Says FCA Suit Over Crashed Plane Parts Can't Fly
• Female Powerbrokers Q&A: McAndrews' Nabeela Rasheed
• Female Powerbrokers Q&A: Crowell's Ellen Dwyer
• High Court's CAFA Ruling Won't Affect AG Enforcement
• McGuireWoods Can Represent Freedom For Now, Judge Says
• Merck To Pay $100M To End NuvaRing Blood Clot Suits
• Reps. Float Bill To Safeguard Private Chemical Sites
• FDA Details Expectations For Approval Of New Painkillers
• Chevron Shakes NJ Claims In MDL Over MTBE Pollution
• Pfizer Wants Professor's Report Out Of Birth Defect MDL
• FDA Sets New Safety Standards For Infant Formula
• Calif. Agency Decision Dooms 'Organic' Label Suit, Hain Says
• Fla. High Court Takes Flexible View Of Self-Insured Retentions
• Citgo Fined $2M Over Refinery Emissions, Bird Deaths
• FirstEnergy Unit Hit With Pa. Coal Plant Pollution Suit
• HP Fails To Power Off Laptop Marketing Action
• Food Giants Push For Federal, Voluntary GMO Labeling
• Judge Sanctions Cal Fire $32M For Conduct In Wildfire Suit
• Chinese Toilet-Part Maker Escapes Insurers' Defect Suit
• Female Powerbrokers Q&A: Wendel Rosen's Pamela Mintzer
• Female Powerbrokers Q&A: Hodgson Russ' Yalamanchili
• Juice Maker Pumps Up Price With False 'Raw' Label, Suit Says
• Litigation Costs Are In Your Control, So Take Control
• SPHC Claims Deadline Applies To All Creditors, Judge Says
• McGuireWoods' Links To Freedom Questioned In Ch. 11 Case
• Out of Ch. 11, W.R. Grace Pays $63M Toward Enviro Cleanup
• Train Derailment Victims Object To Paul Hastings Hiring
• Abbott Hit With 5 AndroGel Suits In FDA Probe's Wake
• FDA Pushes For $225M In User Fees To Finish FSMA
• What Defense Counsel Can Learn From The W.Va. Spill
• Ex-CEO Wants Finances Kept From CPSC In 'Buckyballs' Row
• J&J Punished For Losing Evidence In Vaginal Mesh MDL
• Public Nuisance Case May Change PL Law In Calif.
• Cancer Cluster Plaintiff Blasts Rohm & Haas Pa. Appeal Bid
• Vinson & Elkins Partners Form Litigation Firm In Houston
• 3 Oil Cos. Face Fines For Mislabeling Crude Rail Shipments
• Female Powerbrokers Q&A: Taft's Margaret Lawson
• Female Powerbrokers Q&A: Frankfurt's Barbara Shiers
• Ex-Redskins QB Shakes Prostate Drug False-Ad Suit
• Widowed Asbestos Claimant Can't Shield Claim Forms
• RJ Reynolds Hit With $5M Verdict For Smoker's Death
• 9th Circ. Urged To Reinstate Expert In Novartis Jaw Injury Suit
• Dell Wins Bid For Arbitration In Defective Laptop Suit
• Trucking Co. Escapes $178M Award Over Fatal Crash
• Drugmakers Tackle Biosimilars Oversight At FTC Forum
• FDA Can Regulate Stem Cell Treatments, DC Circ. Rules
• Calif. City Sues CPUC To Publicize Pipeline Explosion Docs
• Negligent Drug Design Claims May Increase In Pa.
• NFL Plaintiffs Target Seau Family Criticism Of $760M Deal
• Coal Ash Woes Mount For Duke As Spill Fouls NC River
• W.Va. Officials Press For Federal Chemical Storage Reforms
• Insurer Challenges $2M Oil Rig Damage Claim
• Female Powerbrokers Q&A: Michelman's Mona Hanna
• Female Powerbrokers Q&A: Baker Donelson's Linda Klein
• Jury Finds Honda Not Liable In Fatal La. Crash
• Biomet To Pay $56M To Settle Hip Replacement MDL
• In-House Counsel Name Client-Friendly Litigators
• GCs Name Favorite Product Liability Attys
• Tempt Hempmilk Accused Of Bogus Sugar Labeling
• Gruma Can't Rely On FDA To Nix Labeling Action, Judge Told
• Gulf Spill Claimants' Attys Call For Sanctions Over BP Ads
• GCs Name Best-Of-The-Best Attys
• Victim Of Steroid-Tainted Supplement Wins $4M In Settlements
• Deferred Sanctions Leave Hope For Takeda In Actos MDL
• Miami Widow Sues Philip Morris Over Smoker's Death
• FDA Floats Criteria To Gauge Food Contamination Risks
• $3.3M Judgment Against Nature's Upheld In Prolab Row
• Smart Balance Milk Labeling Suit Not Preempted, Judge Says
• 3M, GE, Others Ink Cleanup Deal Over Ohio Superfund Site
• NJ Court Revives $18M Condo Defects Suit
• Rohm & Haas Brings Cancer Cluster Suit To Pa. High Court
• Female Powerbrokers Q&A: Holwell Shuster's Dorit Black
• Female Powerbrokers Q&A: Gibbons' Christine Amalfe
• 1st Circ. Holds FCA Relator's Feet To The Rule 9(b) Fire
• Don't Apply Risk Analysis To Discounted Settlement Value